Related Experiment Video
Updated: Jan 20, 2026
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Astilbin reduces ROS accumulation and VEGF expression through Nrf2 in psoriasis-like skin disease
Wuyuntana Wang1,2, Yuhai3, Huan Wang1
1Department of Mongolian Pharmacy, School of Mongol Medicine, Inner Mongolia University for Nationalities, 536 West of Huolinhe Street, Tongliao, 028000, Inner Mongolia, People's Republic of China.
Background:
Psoriasis is a common and intractable skin disease affecting the physical and mental health of patients. The accumulation of ROS is involved in the pathogenesis of psoriasis and antioxidants are believed to be therapeutic. This study aimed to investigate the therapeutic efficacy of astilbin on ROS accumulation in psoriasis.
Results:
The study showed that 50 μg/ml astilbin could inhibit the growth and reduce the accumulation of ROS in HaCaT cells stimulated by IL-17 and TNF-α. Astilbin could elevate the Nrf2 accumulation in the nuclei, eventually leading to the transcriptional activation of various antioxidant proteins and reducing the expression of VEGF.
Conclusions:
Our results collectively suggest that astilbin could induce Nrf2 nucleus translocation, which is contribute to reduce the ROS accumulation and VEGF expression, and inhibit the proliferation of HaCaT cells.
Related Concept Videos
11:39The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
02:28Measuring Psoriasis Severity at Home
01:23Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
03:50ROS Detection with DCFH-DA Staining: Measuring Total ROS in Colorectal Cancer Cell Lines
06:34SCAnED - An Open-source Skin Segmentation Macro for Semi-automated Cell and Nuclei Detection in Epidermal and Dermal Skin Compartments
03:47Determination of ROS Production by Neutrophils upon Interaction with Opsonized Biofilm